Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Primary Biliary Cirrhosis Clinical Research Samples

Discovery Life Sciences provides the highest quality Primary Biliary Cirrhosis Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Primary Biliary Cirrhosis Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 17 of 17 total samples
Advanced Data View:
Showing 17 of 17 total samples
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Test 2Test Data 2Sample Detail 2Test 3Test Data 3Sample Detail 3Product
Additional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Detail 2Additional Information 3Additional Data 3Additional Detail 3Additional Information 4Additional Data 4Additional Detail 4Additional Information 5Additional Data 5Additional Information 6Additional Data 6Additional Information 7Additional Data 7Additional Detail 7ICD10 codes
DLS16-13638-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.001.00$150.0050 YFWhite<-70C20-Feb-17Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundCholelithiasis18-Jan-14N/AN/AN/A$150.00Initial Date of Disease Diagnosis25-Mar-2015Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesCREST SyndromeCurrent Prescription MedicationsUrsodiol; Ibuprofen
DLS16-87712-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.002.00$150.0056 YMBlack<-70C28-Sep-17Clinical DiagnosisPrimary Biliary CirrhosisCT AbdoMenCirrhosis and portal hypertension. Upper abdoMinal ascites.29-Jul-17$150.00Initial Date of Disease DiagnosisMar-15Ever Developed JaundiceNoLiver BiopsyNoCirrhosis?YesCT AbdoMen 29-Jul-2017 ComorbiditiesAwaitng For organ transplant status, Esophageal varice, AdjustMent disorderCurrent Prescription medicationsCiproFloxacin HCL, Docusate sodiuM, Ferrous sulFate, FuroseMide, OMeprazole, Propanolol, SpironolactoneAll Known Test Results Performed in Previous Six monthsALT: 35 U/L, AST: 41 U/L Bilirubin (direct): 1.2 Mg/dL, Bilirubin (total): 2.6 Mg/dL 7-Jul-2017
DLS16-87726-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.003.00$150.0060 YFBlack<-70C20-Jun-17Clinical DiagnosisPrimary Biliary CirrhosisChest x-rayNorMal and No acute process 15-Jan-16 MRI AbdoMen Colonic diverticulosis. No evidence For cirrhosis.15-Oct-14$150.00Initial Date of Disease DiagnosisNov-2014Ever Developed JaundiceNoLiver BiopsyYesFindings are nonspeciFic and not unequivocally diagnostic For autoiMMune hepatis and priMary sclerosing cholangitis. 3-Nov-2014 Cirrhosis?NoComorbiditiesGERD, Fatty liver, Pre-diabetes, OsteopeniaCurrent Prescription medicationsAlbuterol, Atenolol, Benzonatate, Cetirizine, CholecalciFerol, Felodipine, Fluticasone, Lisinopril Mononitrate, Nitroglycerin, Ranitidine, UrodiolAll Known Test Results Performed in Previous Six monthsALT: 16 U/L, AST: 19 U/L Bilirubin (direct): <0.1 Mg/dL, Bilirubin (total): 0.3 Mg/dL 5-Jun-2017
DLS16-82848-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.003.00$150.0045 YFWhite<-70C03-Jul-17Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundUnremarkable27-May-17$150.00Initial Date of Disease Diagnosis5-Jun-2017Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesPsoriatic arthritis, Status post-cholecystectomy and gastric bypass, ADHDCurrent Prescription MedicationsUrsodiol, Vyvanse, Adderall, Cymbalta, RestorilAll Known Test Results Performed in Previous Six MonthsALT: 100 U/L; AST: 106 U/L; GGT: 250 U/L; Bilirubin (direct): 0.12 mg/dL; Bilirubin (total): 0.2 mg/dL 26-May-2017;
DLS17-038155-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.002.00$150.0055 YFWhite<-70C31-Oct-17Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundLiver has persistent increased echogenicity suggesting fatty deposits3-Sep-10MRI Cirrhotic changes of the liver parenchyma. No focal hepatic lesions. Mildly cirrhotic-appearing liver with splenomegaly2-Nov-16$150.00Initial Date of Disease Diagnosis18-Dec-2009Ever Developed JaundiceNoLiver BiopsyYes | Dec-09Non-alcoholic steatohepatitis with advanced fibrosis / pre-cirrhotic or near cirrhotic stateCirrhosisYes | 7-Dec-12MRIComorbiditiesHypertension, Diabetes, GERDCurrent Prescription MedicationsPantoprazole sodium, Ocaliva, Sucralfate, Lantus, NovologAll Known Test Results Performed in Previous Six MonthsALT: 23 U/L; AST: 37 U/L; Bilirubin (total): 0.4 mg/dL; Cholesterol: 203 mg/dL; Triglycerides: 215 mg/dL; HDL: 35 mg/dL; LDL: 132 mg/dL 31-Oct-2017
DLS16-13643-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.004.00$150.0054 YFWhite<-70C02-Feb-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundMild Hepatomegaly, Splenomegaly, Cholelithiasis19-May-17$150.00Initial Date of Disease Diagnosis2004Ever Developed JaundiceNoLiver BiopsyYesPBC Stage 1 | 19-Jan-01 , PBC | 22-Sep-17CirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsUrsodiolAll Known Test Results Performed in Previous Six monthsALT: 32 U/L | AST: 33 U/L | GGT: 133 U/L | Bilirubin (direct): 6 umol/L | Bilirubin (total): 13 umol/L 13-Jan-2018 | Chol: 6.47 mmol/L | Trig: 0.96 mmol/L HDL: 1.92 mmol/L | LDL: 4.11 mmol/L | 14-Sep-2017
DLS16-13609-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.008.00$150.0056 YFWhite<-70C16-Mar-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundNormal Liver7-Jul-17$150.00Initial Date of Disease Diagnosis12-May-2017Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsUrsodialAll Known Test Results Performed in Previous Six monthsALT: 28 U/L | AST: 23 U/L | GGT: 72 U/L | Bilirubin (direct): 4 umol/L | Bilirubin (total): 12 umol/L 2-Feb-2018
DLS16-13610-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.007.00$150.0050 YFWhite<-70C16-Mar-18Clinical DiagnosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis2008Ever Developed JaundiceNoLiver BiopsyYes | Grade 2 PBC; Stage 1 fibrosis2008CirrhosisNoComorbiditiesDepressionCurrent Prescription MedicationsUrsodial; Depo-Provera shotAll Known Test Results Performed in Previous Six monthsALT: 10 U/L | AST: 11 U/L | GGT: 11 U/L | Bilirubin (direct): <2 umol/L | Bilirubin (total): 3 umol/L 30-Jan-2018 | Chol: 4.69 mmol/L | Trig: 2.37 mmol/L | HDL: 1.44 mmol/L | LDL: 2.17 mmol/L | 13-Feb-2018
KH18-16880Primary Biliary CirrhosisUSAK2 EDTA Plasma1.501.00$75.0066 YMWhite<-70C13-Apr-18Abbott Architect20 U/L : ALTAbbott Architect17 U/LAST$75.00BMI27.24Height | Weight177.8 | 86.1K74.3
DLS16-13611-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.0010.00$150.0054 YFAmerican Indian<-70C20-Apr-18Clinical DiagnosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis13-Jun-11Ever Developed JaundiceNoLiver BiopsyYes | 30-40% Macrovesicular steatosis. Rare locus of steatohepatitis.18-Nov-10CirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsUrsodial; Vitamin C; Vitamin DAll Known Test Results Performed in Previous Six monthsALT: 43 U/L | AST: 30 U/L | GGT: 69 U/L | Bilirubin (direct): 0 umol/L | Bilirubin (total): 14 umol/L | 11-Apr-2016
DLS17-026143-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.003.00$150.0045 YFBlack<-70C30-Mar-18Clinical DiagnosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis13-Mar-18Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesGERD, Rectal bleeding, Pre-diabetes, Hypertension, Tobacco dependenceCurrent Prescription MedicationsAmitriptyline, Amlodipine, Clonazepam, Gabapentin, Naproxen, Omeprazole, Prednisone, Varenicline, LoratadineAll Known Test Results Performed in Previous Six monthsALT: 32 U/L | AST: 28 U/L | GGT: 75 U/L | Bilirubin (total): 0.4 mg/dL | 13-Mar-2018 | Cholesterol: 198 mg/dL | Triglycerides: 126 mg/dL | HDL: 65 mg/dL | LDL: 108 mg/dL | 12-Feb-2018
DLS16-87714-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.003.00$150.0059 YFWhite<-70C12-Dec-17Clinical DiagnosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis22-Jun-05Ever Developed JaundiceNoLiver BiopsyNoCirrhosisYes | CT Liver07-Oct-14ComorbiditiesPrimary cholangitis, Asthma, Hepatic encephalopathyCurrent Prescription MedicationsTylenol, Vitamin D, Furosemide, Hydroxyzine, Lactulose, Ursodiol, Tramadol, Omeprazole, RifaximinAll Known Test Results Performed in Previous Six monthsALT: 20 U/L | AST: 22 U/L | Bilirubin (direct): 0.4 mg/dL | Bilirubin (total): 2.1 mg/dL | 12-Dec-2017
DLS16-87716-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.004.00$150.0056 YFWhite<-70C23-Feb-18Clinical DiagnosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis15-Feb-18Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesAbnormal liver enzymes, Anemia, Fibromyalgia, Gastric antral vascular ectasia, Hypothyroidism, Vitamin D deficiencyCurrent Prescription MedicationsFerrous sulfate, LevothyroxineAll Known Test Results Performed in Previous Six monthsNone
DLS17-038147-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.005.00$150.0049 YFWhite<-70C05-Feb-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundNo evidence of fatty liver. Gallstones present.Jun-14$150.00Initial Date of Disease DiagnosisJun-2014Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsVyvanse, Zoloft, Wellbutrin XL, Ursodiol, AllegraAll Known Test Results Performed in Previous Six monthsNone
DLS17-038143-K2Primary Biliary CirrhosisUSAK2 EDTA Plasma1.005.00$150.0074 YFWhite<-70C03-May-18Clinical DiagnosisPrimary Biliary CirrhosisCTCirrhotic hepatic morphology. Mild splenomegaly raised the question of portal hypertension10-Sep-10MRICirrhotic appearance of liver1-Mar-10$150.00Initial Date of Disease Diagnosis2009Ever Developed JaundiceNoLiver BiopsyNoCirrhosisYes | 1-Mar-2010 MRI of abdomenComorbiditiesReflux, Thyroid disease, Hypertension, High cholesterol, Renal insufficiency.Current Prescription MedicationsUrsodiol, Synthroid, Lisinopril, Dicyclomine HCL, Promethazine HCL, Propranolol HCL, Bethanechol chlorideAll Known Test Results Performed in Previous Six monthsALT: 141 U/L | AST: 271 U/L | Bilirubin (total): 0.4 mg/dL 25-Apr-18
DLS16-13615-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.009.00$150.0064 YFWhite<-70C14-May-18Clinical DiagnosisPrimary Biliary Cirrhosis$150.00Initial Date of Disease Diagnosis27-Nov-03Ever Developed JaundiceNoLiver BiopsyYes | PBC5-Jan-04CirrhosisNoComorbiditiesPsoriasis, Rheumatoid arthritis, GERDCurrent Prescription MedicationsUrsodiol, Nadolol, Nexium, Methotrexate, Hydroxychloroquine, Tramadol, AmitriptylineAll Known Test Results Performed in Previous Six monthsALT: 24 U/L | AST: 20 U/L | GGT: 16 U/L | Bilirubin (total): 8 umol/L 14-May-18
DLS16-13617-K2Primary Biliary CirrhosisCanadaK2 EDTA Plasma1.008.00$150.0038 YMWhite<-70C25-Oct-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundFatty infiltration. Liver is coarse and homogeneous6-Jun-18MRIDiffuse abnormality of intrahepatic portal veins23-Oct-16$150.00Initial Date of Disease Diagnosis14-Aug-2017 (Diagnosed by liver biopsy)Ever Developed Jaundicefibrosis, mild non-specific inflammation, mild bile ductular reaction28-Sep-16Liver BiopsyNoCirrhosis?NoComorbiditiesNoneCurrent Prescription medicationsUrsodiolAll Known Test Results Performed in Previous Six monthsALT: 119 U/L | AST: 85 U/L | GGT: 196 U/L | Bilirubin (direct): 6 umol/L | Bilirubin (total): 12 umol/L | 23-Oct-2018

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.